Pharmacology Case Study

796 Words 4 Pages
Names and qualifications of all relevant personnel, with biosketch forms completed

● Key Individuals

○ Co-PIs:
○ Michael A. Burman Ph.D. Assistant Professor, Dept. of Psychology. K-12 Neuroscience Outreach Coordinator. PI on NIH AREA grant.
○ Edward Bilsky Ph.D. Professor, Department of Biomedical Sciences, COM. Vice President for Research and Scholarship. Senior faculty member and senior administrator at UNE, over 70 publications in opioid, addiction and pain fields with continuously funded laboratory for over 15 years.
○ Susan Hillman Ph.D. Director, Center for Excellence in Teaching and Learning. Co-PI on NSF GK-12 grant. Several recent presentations on science attitudinal assessment and education related to this grant.
○ Christian
…show more content…
Assistant Professor of Pharmacology. NIH funding and publications in ligand-receptor interactions.
○ Karen Houseknecht Ph.D. Professor of Pharmacology. Over 50 publications on Pharmacology and Addiction. Co-I on NIH U01 award. PI on several R01s.
○ Glenn Stevenson Ph.D. Associate Professor of Psychology. NIH funding to study analgesia, opiate pharmacology and addiction.
○ John Streicher Ph.D. Assistant Professor of Biomedical Sciences. Research on opioid pharmacology and addiction potential.
○ Amy Deveau Ph.D. Associate Professor, Dept. of Chemistry. Published papers on molecular modeling, including opiate pharmacology.
○ Robert Lenox M.D. Clinical Professor, Dept. Biomedical Sciences, COM. Distinguished career in Psychiatry and Neuropsychopharmacology including both academic medicine and industry
○ Ian Meng Ph.D. Professor, Department of Biomedical Sciences, COM. Director, Center for Excellence in the Neurosciences. PI of NIH COBRE grant.
○ Daniel Selvage, Ph.D. Associate Professor, College of Pharmacy. Research on alcohol and HPA-axis function.

External Evaluators and
…show more content…
Formative evaluation components will provide ongoing data regarding both participation levels and outcomes to inform program decisions and staff activities. Summative components will provide data for assessing program progress toward intended outcomes, including both the short-term and long-term metrics. The evaluation will feature a collaboration between PEER and program stakeholders with the goal of ensuring that evaluation findings are of high value and use to the highest priority stakeholders.

Evaluation Design

Our proposed evaluation takes place in phases; the process will respond to and accommodate emerging needs and opportunities as they arise. The phases and major activities for each phase are described below. The timing of these evaluation phases will be aligned with implementation of project activities.

1. Planning and needs assessment
The Neuroscience for Neighborhoods project envisions a rich and complex collaboration among researchers, undergraduate students, health professional students, science and education faculty, and K-12 school teachers, administrators and students. Because successful project implementation will depend on well-informed planning, this phase of the evaluation will seek to provide program staff with relevant data. PEER-facilitated evaluation activities during this phase will include the

Related Documents